Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nephrolithiasis as a systemic disorder.

Khashayar Sakhaee1

  • 1The Charles and Jane Pak Center for Mineral Metabolism and Clinical Research, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75290-8885, USA. Khashayar.Sakhaee@utsouthwestern.edu

Current Opinion in Nephrology and Hypertension
|April 15, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From stones to system: integrating kidney stones disease into the cardiovascular-kidney-metabolic continuum.

Current opinion in nephrology and hypertension·2026
Same author

Vitamin D in Chronic Kidney Disease: Familiar Treatment, Unresolved Questions.

American journal of nephrology·2025
Same author

Acute Effect of High Fat Intake on Urinary Acidification Parameters.

Kidney international reports·2025
Same author

SGLT-2 inhibitors for the prevention of recurrent nephrolithiasis.

BMJ (Clinical research ed.)·2024
Same author

Fat Distribution and Urolithiasis Risk Parameters in Uric Acid Stone Formers and Patients with Type 2 Diabetes Mellitus.

Clinical journal of the American Society of Nephrology : CJASN·2024
Same author

Gaps in kidney stone disease management: From clinical theory to patient reality.

Urolithiasis·2024
Same journal

Primary prevention of chronic kidney disease in type 2 diabetes mellitus with sodium-glucose cotransporter 2 inhibitors.

Current opinion in nephrology and hypertension·2026
Same journal

Financial and policy challenges of delivering kidney replacement therapies in resource-limited settings.

Current opinion in nephrology and hypertension·2026
Same journal

The role of kir4.1/Kir5.1 in mediating the effect of angiotensin-II on Na-Cl-cotransporter.

Current opinion in nephrology and hypertension·2026
Same journal

Role of the calcium-sensing receptor in regulating calcium transport in the thick ascending limb.

Current opinion in nephrology and hypertension·2026
Same journal

Social determinants of chronic kidney disease: from association to clinical and population action.

Current opinion in nephrology and hypertension·2026
Same journal

Advancing science and care in CKD-MBD: the layered path to legacy.

Current opinion in nephrology and hypertension·2026
See all related articles

Kidney stones (nephrolithiasis) are linked to obesity and high blood pressure. Understanding these connections may lead to better prevention and treatment strategies for this common health issue.

Area of Science:

  • Nephrology
  • Epidemiology
  • Public Health

Background:

  • Nephrolithiasis represents a significant public health concern with considerable economic impact.
  • Emerging evidence suggests kidney stones are a systemic illness, not merely a localized condition.
  • Epidemiologic studies reveal associations between nephrolithiasis, obesity, hypertension, and chronic kidney disease.

Purpose of the Study:

  • To review emerging studies on nephrolithiasis.
  • To highlight the systemic nature of kidney stones.
  • To explore the link between kidney stones and metabolic syndrome.

Main Methods:

  • Review of cross-sectional retrospective studies.
  • Analysis of epidemiologic data.
  • Synthesis of emerging research findings.

Related Experiment Videos

Main Results:

  • Metabolic syndrome components are increasingly recognized as risk factors for kidney stone formation.
  • Obesity (increased BMI), hypertension, type 2 diabetes, and dyslipidemia are independently associated with higher kidney stone risk.
  • These findings support the view of kidney stones as a manifestation of systemic metabolic disturbances.

Conclusions:

  • Further elucidation of the mechanisms linking nephrolithiasis and metabolic syndrome is crucial.
  • Enhanced understanding will drive the development of improved preventive and therapeutic interventions.
  • Recognizing kidney stones as a systemic illness is vital for comprehensive patient care.